Evidence map›Paper›PMID 42029633›Full record

ArticleJournal of neuromuscular diseases2026

A qualitative study of the discrepancy between patient expectations and assessment practices in 5q-adult spinal muscular atrophy in France.

Guillaume Montagu, François-Constant Boyer, Marcela Gargiulo, Samuel Pouplin, Aurélie Barrière, Edouard Berling, Céline Bonnyaud, Pascal Cintas, Jean-Yves Hogrel, Lucie Le Goff and 11 more

Abstract read
In one paragraph

Article in Journal of neuromuscular diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Guillaume MontaguUnknowns SAS, Social Science Research, Paris, France.ORCID 0009-0006-0482-6493
François-Constant BoyerService de Médecine Physique et Réadaptation, CHU de Reims, Reims, France.ORCID 0000-0003-1035-9108
Marcela GargiuloInstitut de Myologie, Hôpital de la Pitié-Salpêtrière, APHP, Paris, France.
Samuel PouplinLaboratoire d'analyse du mouvement, Hôpital Raymond-Poincaré, APHP Paris, Garches, France.
Aurélie BarrièreConsultations pluridisciplinaires des maladies neuromusculaires - Hôpital de la croix rousse, CHU Lyon - L'Escale, Hôpital Femme Mère Enfant, Lyon, France.
Edouard BerlingService de Neurologie, Centre de référence des maladies neuromusculaires Nord Est IDF, Hôpital Raymond-Poincaré, APHP Paris, Garches, France.
Céline BonnyaudLaboratoire d'analyse du mouvement, Hôpital Raymond-Poincaré, APHP Paris, Garches, France.
Pascal CintasDépartement de Neurologie, Hôpital Pierre-Paul Riquet, CHU de Toulouse, Toulouse, France.
Jean-Yves HogrelInstitut de Myologie, Hôpital de la Pitié-Salpêtrière, APHP, Paris, France.
Lucie Le GoffHôpital Mère-Enfant, médecine pédiatrique, CHU Nantes, Nantes, France.
Brice MarchadierRoche SAS, Medical Affairs, Boulogne-Billancourt, France.
Ghislain N'Dah SekouService de Neurologie, Centre de référence des maladies neuromusculaires Nord Est IDF, Hôpital Raymond-Poincaré, APHP Paris, Garches, France.
David OrlikowskiFHU PHENIX, Garches, France.
Hélène PrigentFHU PHENIX, Garches, France.
Alexandra PruvotRoche SAS, Medical Affairs, Boulogne-Billancourt, France.
Juliette RoparsService de neurologie pédiatrique, CHU de Brest, Brest, France.
Emmanuelle Salort-CampanaService des Maladies Neuromusculaires et de la SLA, Hôpital de la Timone, APHM, Marseille, France.
Tanya StojkovicInstitut de Myologie, Hôpital de la Pitié-Salpêtrière, APHP, Paris, France.
Guillaume NicolasService de Neurologie, Centre de référence des maladies neuromusculaires Nord Est IDF, Hôpital Raymond-Poincaré, APHP Paris, Garches, France.
Sharam AttarianService des Maladies Neuromusculaires et de la SLA, Hôpital de la Timone, APHM, Marseille, France.
Pascal LaforêtService de Neurologie, Centre de référence des maladies neuromusculaires Nord Est IDF, Hôpital Raymond-Poincaré, APHP Paris, Garches, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite advancements in spinal muscular atrophy (SMA) management, evaluating outcomes in adults remains difficult. Standard motor scales often show floor/ceiling effects and fail to capture patient-relevant constructs. This creates a disconnect between clinical measurements and the lived experience of adults with SMA, particularly in regulatory contexts requiring demonstrable benefit. This qualitative study explored the evaluation priorities, expectations, and preferences of adults with SMA and the corresponding assessment challenges faced by healthcare practitioners (HCPs).

methodsSemi-structured interviews with 18 adults with SMA (types 1b-3) and 31 multidisciplinary HCPs from 14 specialized French centers were conducted. Data were analyzed using reflexive thematic analysis and triangulation.

resultsAdults with SMA found standard assessments burdensome, fatiguing, and lack relevance. Their primary goal was maintaining an DISCUSSION: A discrepancy exists between current standardized SMA assessments and patients priorities. It highlights a need for outcome measures that align with patients' priorities, particularly "keystone abilities." HCPs' innovative approaches offer a promising direction for future assessment development, advocating for a shift towards individualized, holistic evaluation in SMA care.

Indexed as

acceptable life balanceenvironmental adaptationhealthcare professional practiceskeystone abilitiesmotor function assessmentpatient-centered assessmentpersonalized healthcarequalitative studyquality of lifespinal muscular atrophy

Identifiers

PMID42029633
PMCPMC13442924

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.